Survey: 40% of Americans’ Daily Lives are Disrupted by Digestive Troubles

The American Gastroenterological Association (AGA) recently launched Trust Your Gut, an awareness campaign aimed at shortening the time from the onset of bowel symptoms to discussions with a health care provider. As part of the campaign, AGA released new data that shows nearly 40% of Americans have stopped routine activities in the last year due to uncomfortable bowel symptoms, including ...

Read More »

Business Partnership May Increase Delivery of Gut-Directed Hypnotherapy for IBS Patients

GI OnDEMAND, a virtual integrated care platform, recently announced a partnership with Mindset Health, the creator of Nerva, a six-week gut-directed hypnotherapy program. The hypnotherapy program is delivered through a mobile app to help patients with irritable bowel syndrome (IBS) better manage their symptoms. GI OnDEMAND is a joint venture between the American College of Gastroenterology and Gastro Girl, Inc., ...

Read More »

Survey: 40% of Americans’ Daily Lives are Disrupted by Digestive Troubles

BETHESDA, Md.—In September, the American Gastroenterological Association (AGA) launched Trust Your Gut, an awareness campaign aimed at shortening the time from the onset of bowel symptoms to discussions with a healthcare provider. As part of the campaign, AGA released new data that shows nearly 40% of Americans have stopped routine activities in the last year due to uncomfortable bowel symptoms, ...

Read More »

2022 Gastroparesis Awareness Month: The Burdens, Concerns, and Quality of Life for Individuals

MOUNT PLEASANT, S.C.—Gastroparesis Awareness Month, established by IFFGD in 2016, takes place every year during the month of August. IFFGD utilizes its platform to support the gastroparesis community by raising awareness to promote education and encourage research. Gastroparesis is a chronic gastrointestinal (GI) disorder affecting approximately 5 million people in the United States and about 38 women and 10 men ...

Read More »

FDA Alert: Change in Reprocessing Methods for Certain Karl Storz Urological Endoscopes

The U.S. Food & Drug Administration recently issued a letter to healthcare providers regarding changes to reprocessing methods for certain urological endoscopes manufactured by Karl Storz, due to infection risk. The letter can be found here. An excerpt follows: “As the U.S. Food and Drug Administration (FDA) continues to evaluate the risk of patient infections and contamination issues associated with ...

Read More »